Yingxin Sun

Hangzhou, 311121, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Fluorescent self-reporting theranostic platforms for tumour therapy: from cytotoxin release monitoring to therapeutic feedback evaluation.

Fluorescent self-reporting theranostic platforms for tumour therapy: from cytotoxin release monitoring to therapeutic feedback evaluation.

Journal: Journal of materials chemistry. B
Published: May 01, 2026

Multimodal Nanobubbles Carrying Indocyanine Green and VCAM-1 Targeting Peptide for Molecular Imaging of DOX-Induced Cardiotoxicity.

Multimodal Nanobubbles Carrying Indocyanine Green and VCAM-1 Targeting Peptide for Molecular Imaging of DOX-Induced Cardiotoxicity.

Journal: International journal of nanomedicine
Published: March 04, 2026

The efficacy of varying doses of venetoclax combined with azacitidine for newly diagnosed adult acute myeloid leukemia in real-world settings: a single-center retrospective analysis.

The efficacy of varying doses of venetoclax combined with azacitidine for newly diagnosed adult acute myeloid leukemia in real-world settings: a single-center retrospective analysis.

Journal: Hematology (Amsterdam, Netherlands)
Published: October 14, 2025

Distinct clinical profiles and patient outcomes in aCML and CNL.

Distinct clinical profiles and patient outcomes in aCML and CNL.

Journal: Annals of hematology
Published: September 01, 2024

High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.

High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China.

Journal: Annals of hematology
Published: February 21, 2024

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab.

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab.

Journal: Frontiers in pharmacology
Published: February 10, 2023

Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia.

Molecular genetics and management of world health organization defined atypical chronic myeloid leukemia.

Journal: Annals of hematology
Published: October 23, 2022

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World.

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World.

Journal: Frontiers in oncology
Published: October 19, 2021

OSR1 suppresses acute myeloid leukaemia cell proliferation by inhibiting LGR5-mediated JNK signalling.

OSR1 suppresses acute myeloid leukaemia cell proliferation by inhibiting LGR5-mediated JNK signalling.

Journal: Autoimmunity
Published: September 14, 2021

Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review.

Diagnosis and Treatment of Myeloproliferative Neoplasms With PCM1-JAK2 Rearrangement: Case Report and Literature Review.

Journal: Frontiers in oncology
Published: August 05, 2021

Overexpression of FOXA2 attenuates cigarette smoke-induced cellular senescence and lung inflammation through inhibition of the p38 and Erk1/2 MAPK pathways.

Overexpression of FOXA2 attenuates cigarette smoke-induced cellular senescence and lung inflammation through inhibition of the p38 and Erk1/2 MAPK pathways.

Journal: International immunopharmacology
Published: September 15, 2020

Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.

Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.

Journal: BioMed research international
Published: November 14, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026